Merck in late-stage talks to acquire Prometheus Biosciences

Merck & Co is in late-stage
talks to acquire Prometheus Biosciences Inc to get its
hands on promising immune disease treatments, the Wall Street
Journal reported on Sunday citing people familiar... | April 16, 2023

Related Keywords

Bengaluru , Karnataka , India , Kanjyik Ghosh , Tom Hogue , Reuters , Merck Co , Prometheus Biosciences Inc , Wall Street Journal , Wall Street , Prometheus Biosciences , Nc Stock Exchange , News , Information , Press Release , Merck , O , Us , N , Cquire , Prometheus , Iosciences , Nc , Pet , Romising , Immune , Disease , The , Wall , Eported , Sunday , Writing , Eople Rxdx Us74349u1088 ,